secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0000950170-25-014601
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health shareholders approve reverse stock split authorization (1:2 to 1:30)
--------------------------------------------------------------------------------

- Reverse split ratio range authorized: 1-for-2 to 1-for-30, at board discretion within 12 months.
- Proposal passed with 3,028,943 votes for, 243,254 against, 33,240 abstentions.
- Quorum was 34.9% (3,305,437 of 9,467,327 outstanding shares).
- Adjournment proposal also approved but not needed; meeting not adjourned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025014601/0000950170-25-014601-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025014601/tivc-20250131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-014601

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer